• Digital therapeutics provider Happify Health has partnered with neuroscience-focused pharma company Biogen to develop an AI-powered digital patient engagement and education tool for individuals diagnosed with multiple sclerosis (MS).  

• The tool will include access to Happify Health’s community for patients diagnosed with MS as well as access to neurology providers, mental health providers, dieticians, and rehabilitation professionals. The tool will also include curated educational content provided by Biogen. 

<ul><li> This announcement marks the third partnership Happify Health has entered into this year, following its partnership with Anthem to improve maternal health and its partnership with Zuellig Pharma to commercialize two of its prescription drug therapeutics in Asia.</ul>